Overview: S 6377, "Requires Medicaid to cover gender-affirming care regardless of federal funding; prohibits discriminatory practices by health care entities and insurers; relates to coverage for treatment for gender dysphoria", was recommitted with the enacting clause stricken. This bill was introduced on March 12, 2025.
Purpose and Intent: The primary goal of S 6377 is to ensure that Medicaid coverage in the state includes gender-affirming care for individuals with gender dysphoria, regardless of whether such care is federally funded. The bill also aims to prohibit discriminatory practices by healthcare entities and insurers related to the provision of gender-affirming treatments.
Key Provisions:
- Requires Medicaid to cover gender-affirming care, including but not limited to hormone therapy, puberty blockers, and surgical procedures
- Prohibits healthcare entities and insurers from discriminating against individuals based on their gender identity or expression
- Establishes a process for individuals to file complaints against entities that engage in discriminatory practices
Affected Parties and Impacts: This bill would directly impact Medicaid recipients in need of gender-affirming care, as well as healthcare providers, insurers, and other entities that offer or administer health coverage in the state. The legislation is intended to improve access to essential medical services and protect the rights of transgender and gender-nonconforming individuals.
Procedural and Timeline Considerations: S 6377 has been recommitted with the enacting clause stricken, indicating that the bill has encountered some procedural hurdles or opposition. The next steps in the legislative process are unclear based on the available information.
